CJ Cheiljedang: Thin Operating Margins, Net Losses and a Share Price Near 0.4x Book Value

Thesis

The data supports a picture of a large, revenue-stable food company whose bottom line has deteriorated. Revenue was ₩27.4T over the trailing twelve months, near the 2025 level of ₩27.3T, and operating income stayed positive at ₩1.0T. However, net income turned negative: ₩-571B in 2025 and ₩-679B over the trailing twelve months, against profits of ₩892B in 2021 and ₩803B in 2022. The market is valuing the equity at 0.4x book value and 0.1x sales, which reflects the earnings decline, but the data does not explain the cause of the net losses. Free cash flow was positive at ₩2.3T, which partly offsets the weak earnings picture. Investor flow, foreign ownership, short balance and news data are not available, so market sentiment cannot be assessed beyond price moves.

Business overview

CJ Cheiljedang is listed on KOSPI in the Food & Beverage sector. It was founded on 2007-09-04 and listed on 2007-09-28, with 15,054,186 listed shares and co-CEOs 손경식 and 윤석환. Market cap is ₩2.74T and enterprise value is ₩3.40T. Revenue has ranged between ₩26.3T (2021) and ₩30.1T (2022) over the last five years, so the company has been consistently large but has not grown since 2022. Among the peers listed, Samyang Foods (₩9.0T), Orion (₩4.2T), Nongshim (₩2.4T), Otoki (₩1.3T) and Lotte Wellfood (₩1.1T), CJ Cheiljedang is the second-largest or close to it by market cap after Orion.

Financial analysis

All figures come from filed financial statements (DART). Revenue fell 6.9% in 2025 to ₩27.3T after growth of 1.2% in 2024, a 3.5% decline in 2023 and 14.4% growth in 2022. Operating income was ₩1.23T in 2025, down from ₩1.55T in 2024, and the operating margin slipped from 5.8% in 2021 to 4.5% in 2025 and 3.8% on a trailing basis. Net income fell from ₩892B in 2021 to ₩148B in 2024 and then to a loss of ₩571B in 2025. Trailing net margin is -2.5% and ROE is -8.9% (versus 14.6% in 2021). The balance sheet shows liabilities to equity of 160.4%, cash of ₩889B and borrowings of ₩1.56T. Trailing free cash flow is ₩2.26T, well above reported net income.

Valuation

Price-to-earnings and EV/EBITDA are not meaningful or not available because of negative earnings and missing data. Price-to-book is 0.4, matching the year-end 2025 figure of 0.4, and price-to-sales is 0.1. Earlier year-end price-to-book figures are not available, so a longer own-history comparison is not possible. The dividend yield is 3.5%. Among peers, Orion trades at a P/E of 10.0 and P/B of 1.0, and Samyang Foods at a P/E of 18.5 and P/B of 5.9; multiples for Nongshim, Otoki and Lotte Wellfood are not available. CJ Cheiljedang's P/B is well below the two peers with data, but those companies are profitable, so the comparison reflects different earnings conditions.

Catalysts

• The 2026-10-02 filing titled 'Major management matter relevant to investors' could matter, but its content is not described in the data.
• The H1 2026 half-year report and preliminary consolidated earnings (filed 2026-08-14 and 2026-08-11) are the latest read on profitability, showing a trailing net loss.
• A cash dividend decision was filed on 2026-08-10, which is relevant given the 3.5% dividend yield.
• Several investor relations events (2026-07-20, 2026-08-05, 2026-08-24) show ongoing engagement with investors.
• The share price is ₩181,900, near the 52-week low of ₩172,600 and well below the high of ₩252,000, so further price moves will reflect upcoming results.

Risks

• Net losses in 2025 and the trailing twelve months mean the company is not currently earning a profit for shareholders, with ROE at -8.9%.
• The operating margin has trended down from 5.8% in 2021 to 3.8% trailing, leaving little cushion.
• Revenue fell 6.9% in 2025 and has not grown beyond its 2022 level of ₩30.1T.
• Liabilities are 160.4% of equity and borrowings are ₩1.56T, which adds financial leverage in a loss-making period.
• Data gaps, including investor flows, foreign ownership, short interest and news, limit the view of market sentiment and the reasons for the losses.

Closing view

The evidence is mixed. Operating profit remains positive, cash flow is strong at ₩2.3T and the shares trade at 0.4x book value with a 3.5% dividend yield. Against that, net losses, falling margins, flat-to-declining revenue and moderate leverage explain much of the share price weakness, down 22.3% over a year. The data does not show the causes of the net losses or whether they are one-off, so the picture depends on information in the filings that is not included here.

Model estimate of fair value

The valuation model has no estimate for this company yet (not enough data, or no positive value with the base case).

Report history

1. Oct 13, 2026InitiationCJ Cheiljedang: Thin Operating Margins, Net Losses and a Share Price Near 0.4x Book Value